Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Gabriel Vidal

Vascular Neurology New Orleans, LA Medical Doctor

NPI 1871788216 CMS profile 176008

1514 Jefferson Highway, New Orleans, LA 70121

Open in the dashboard

General payments

$166,888

258 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$39,187 paid to institutions, not to them · program year 2025

Through program year 2025, Gabriel Vidal of New Orleans, LA is reported in the CMS Open Payments database as having received $166,888 across 258 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $39,187 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 97th percentile of Vascular Neurology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $40,800 46
2024 General $50,723 73
2023 General $32,266 36
2022 General $22,099 29
2021 General $8,888 31
2020 General $375 10
2019 General $11,737 33

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Gabriel Vidal
  • Vascular Neurology median
  • Middle half of Vascular Neurology
  • National median

In program year 2025, general payments to Gabriel Vidal were reported at $40,800. Among 416 Vascular Neurology profiles paid that year, the median was $360 and the middle half received between $91 and $1,472.

Show as a table
Year Gabriel Vidal Vascular Neurology median Middle half National median
2019 $11,737 $263 $102–$1,640 $163
2020 $375 $153 $45–$1,000 $114
2021 $8,888 $261 $100–$1,355 $132
2022 $22,099 $242 $87–$1,273 $149
2023 $32,266 $322 $97–$1,266 $160
2024 $50,723 $247 $70–$1,053 $164
2025 $40,800 $360 $91–$1,472 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Penumbra, Inc. $92,251 123 payments
  2. AstraZeneca Pharmaceuticals LP $57,201 47 payments
  3. Alexion Pharmaceuticals, Inc. $9,313 12 payments
  4. Stryker Corporation $5,490 8 payments
  5. Imperative Care, INc $894 21 payments
  6. MicroVention, Inc. $805 20 payments
  7. DePuy Synthes Sales Inc. $261 4 payments
  8. Siemens Medical Solutions USA, Inc. $134 1 payment
  9. Contego Medical, Inc $130 1 payment
  10. Portola Pharmaceuticals, Inc. $68 3 payments
  11. Other $341 18 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $117,130 41 payments
  2. Travel and Lodging $33,438 70 payments
  3. Food and Beverage $9,003 145 payments
  4. Consulting Fee $7,318 2 payments
Products named General payments · program years 2019–2025
  1. ANDEXXA Rare Disease $58,198 45 payments
  2. Penumbra System Neurointervention $50,216 47 payments
  3. Smart Coil $26,680 17 payments
  4. Andexxa Hematology $8,113 11 payments
  5. RED 72 $6,670 24 payments
  6. TREVO $5,124 2 payments
  7. Penumbra System Neurointervention $3,967 12 payments
  8. ACE $2,400 1 payment
  9. Penumbra Coil 400 $1,960 8 payments
  10. Penumbra SMART Coil $522 5 payments
  11. Other $5,371 143 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 38 billing codes

Paid by Medicare

$59,983

Medicare's payments for the services billed

Medicare patients

151

Average age 73

Services billed

416

78 women, 73 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Ischemic heart disease 50%
Arthritis 50%
Heart failure 41%
Diabetes 38%
Chronic kidney disease 36%
Atrial fibrillation 35%
Depression 33%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

1 product · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
BOTOX
$21 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

Records

258 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Vascular Neurology in Louisiana

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record